Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Lara Marie Akingunsade"'
Autor:
Dawid Głów, Simon Meyer, Irene García Roldán, Lara Marie Akingunsade, Kristoffer Riecken, Boris Fehse
Publikováno v:
Molecular Therapy: Methods & Clinical Development, Vol 22, Iss , Pp 249-262 (2021)
Since the introduction of clustered regularly interspaced short palindromic repeats (CRISPR)/CRISPR-associated protein 9 (Cas9), genome editing has been broadly applied in basic research and applied biotechnology, whereas translation into clinical te
Externí odkaz:
https://doaj.org/article/6f33396e84f94dfc9ac886fa0a5d9a8b
Autor:
Irene García Roldán, Kristoffer Riecken, Simon Meyer, Dawid Głów, Lara Marie Akingunsade, Boris Fehse
Publikováno v:
Molecular Therapy: Methods & Clinical Development, Vol 22, Iss, Pp 249-262 (2021)
Molecular Therapy. Methods & Clinical Development
Molecular Therapy. Methods & Clinical Development
Since the introduction of clustered regularly interspaced short palindromic repeats (CRISPR)/CRISPR-associated protein 9 (Cas9), genome editing has been broadly applied in basic research and applied biotechnology, whereas translation into clinical te
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::44b72aaecc21d909ffa627acfdd456a5
https://doi.org/10.1016/j.omtm.2021.07.004
https://doi.org/10.1016/j.omtm.2021.07.004
Autor:
Jennifer Schröder-Schwarz, Mascha Binder, Savithri Rangarajan, Christian Müller, Udo Schumacher, Nikolaus Möckelmann, Chia-Jung Busch, Tobias Lange, Konstantin Hoffer, Lara Marie Akingunsade, Conrad Droste, Henrike Barbara Zech, Lukas Clemens Böckelmann, Julia Kemmling, Anh Thu Vu, Lara Bußmann, Fruzsina Gatzemeier, Till S. Clauditz, Nina Struve, Malte Kriegs, Konrad Klinghammer, Donjete Simnica, Christian Stephan Betz, Peter Nollau, Cordula Petersen, Agnes Oetting, Thorsten Rieckmann, Adrian Münscher, Rik de Wijn, Arne Böttcher, Joanna Caroline Berger, Clara Marie von Bargen, Kai Rothkamm
Publikováno v:
International journal of cancerREFERENCES. 149(5)
Signal transduction via protein kinases is of central importance in cancer biology and treatment. However, the clinical success of kinase inhibitors is often hampered by a lack of robust predictive biomarkers, which is also caused by the discrepancy
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::116669ed535d5fe54f2652b3feadffbf
https://pubmed.ncbi.nlm.nih.gov/35147982
https://pubmed.ncbi.nlm.nih.gov/35147982